Response to: Pediatric Coccidioidomycosis: Disease Spectrum and Implications for Antifungal Therapy
Journal of the Pediatric Infectious Diseases Society · 06.07.2026 · 15 (7)
DOI: 10.1093/jpids/piag044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 06.07.2026. Verfasst von Sanchi Malhotra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Dear Editor, We thank Dr. Kalkan for his interest in our manuscript published in the April 2026 issue of JPIDS regarding our longitudinal experience with pediatric coccidioidomycosis and for comparing our report with that published by Michienzie et al. in March 2026.1 The 2 papers are complementary in examining the spectrum of disease and clinical experiences in 2 different practice settings in the same geographic area. The study by Michienzie et al. was conducted within the vertically integrated Kaiser Permanente Southern California (KPSC) medical system and enabled a broad summary of children with different variants of coccidioidomycosis within their insurance system. Our study was conducted in an academic medical center to which children throughout southern and central California are sent for subspecialty evaluation, with an equal representation of patients with commercial and Medicaid insurance coverage. Our study population contained a higher percentage of immunocompromised children (9% versus 1.9%) and disseminated cases (28% versus 4.8%) compared to children seen within the KPSC system, and proportionally a higher percentage received antifungal therapy (90% vs 76%). As we emphasized in our discussion, interpretation of our data is limited by referral bias, but this provided a larger number of disseminated cases to identify the features of complicated disease.
Autor:innen und Institutionen
- Department of Pediatrics, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States.
ORCID-Profile: Sanchi Malhotra
Zitieren
APA
Malhotra, S., & Krogstad, P. (2026). Response to: Pediatric Coccidioidomycosis: Disease Spectrum and Implications for Antifungal Therapy. Journal of the Pediatric Infectious Diseases Society, 15(7). https://doi.org/10.1093/jpids/piag044
Vancouver
Malhotra S, Krogstad P. Response to: Pediatric Coccidioidomycosis: Disease Spectrum and Implications for Antifungal Therapy. Journal of the Pediatric Infectious Diseases Society. 2026;15(7). doi:10.1093/jpids/piag044
BibTeX
@article{Malhotra2026,
author = {Malhotra, Sanchi and Krogstad, Paul},
title = {Response to: Pediatric Coccidioidomycosis: Disease Spectrum and Implications for Antifungal Therapy},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2026},
volume = {15},
number = {7},
doi = {10.1093/jpids/piag044}
}
EUVIMED